Complaints about FDA regulatory requirements are not going to solve the underlying reason why some therapeutic areas lack targeted treatments, the agency says in a new report.
In "Targeted Drug Development: Why Are Many Diseases Lagging Behind?," the agency explains that shortfalls in the science, not FDA...